HCPLive Network

Higher Dose of Fulvestrant Associated With Improved Survival in Advanced Breast Cancer

Postmenopausal women with advanced estrogen receptor–positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.

Click here to view this article.

Further Reading
Researchers from the University of Massachusetts Amherst will investigate if a blood test can predict breast cancer.
Breast cancer patients who believed acupuncture would reduce their joint pain demonstrated significant pain reduction, no matter if they received real or placebo acupuncture.
Regular exercise doesn't erase the higher risk of serious illness or premature death that comes from sitting too much each day, a new review reveals. The research is published in the Jan. 20 issue of Annals of Internal Medicine.
More Reading